The emerging occurrence of KHDRBS1–NTRK3 fusion was observed in a patient with KIF5B-RET fusion + LCNEC (large cell neuroendocrine carcinoma) progressing on selpercatinib [98]. Here, RET is linked to large cell neuroendocrine carcinoma.